LC3-II level was tested by western blot. c Cells were treated as described in b, the Aβ 1-42 concentration was measured by an ELISA assay. d Cells were transfected with ERβ and vector plasmids under CQ treatment or not in the HEK293T (AβPPsw) model. Cell lysates were analyzed by immunoblotting for APP, BACE1, Flag, LC3-II, and β-actin protein expression. e Cells were treated as described in d, the Aβ 1-42 concentration was measured by an ELISA assay. f Cells were treated with DPN (10 nM) or Aβ 1-42 (5 μM) for 12 h and then added CQ (10 μM) for another 12 h. The MTT assay was used to test cell viability. g Cells were treated as described in (Fig. 1d) , then the α7nAChR level was tested by western blot. h Cells were treated as described in (Fig. 1b) , then the α7nAChR level was tested by western blot. i Cells were treated as described in (Fig. S2A) , then the α7nAChR level was tested by western blot. Data shown are mean ± S.D. of three independent experiments. (*P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001)
